P2B-049

The Crown Princess Mary Cancer Centre Westmead (Sydney, Australia) › P2B-049

P2B-049

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
The Crown Princess Mary Cancer Centre Westmead (Sydney, Australia) · Dr. Kowalski
consented 2012-11-01

completed

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 oedema peripheral with onset in cycle 2 (2012-12-15); assessed as not related to study drug (not related); resolved 2013-01-21.

mild assessed

Grade 3 neutropenia with onset in cycle 1 (2012-11-21); assessed as related to study drug (probable); resolved 2012-11-27.

severe assessed

Grade 1 stomatitis with onset in cycle 1 (2012-11-18); assessed as related to study drug (probable); resolved 2012-11-26.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.